Citations

Citations to this article as recorded by  

• Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies
  Marina Nishimuni, Laura Carolina Lopez Claro, Maria Ignez Freitas Melro Braghiroli
  Surgical and Experimental Pathology.2024;[Epub]     CrossRef
• Research Progress of MSI Gastric Cancer Subtypes
  成菊 马
  Advances in Clinical Medicine.2022; 12(07): 6719.     CrossRef
• OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome
  Jaishree Pandian, Ponmathi Panneerpandian, Balaji T. Sekar, Karthikeyan Selvarasu, Kumaresan Ganesan
  Functional & Integrative Genomics.2022; 22(6): 1345.     CrossRef
• Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea
  Jeong Ho Song, Yeonkyoung Lee, Jaesung Heo, Sang-Yong Son, Hoon Hur, Sang-Uk Han
  Cancers.2022; 14(24): 6165.     CrossRef
• Microsatellite instability: a review of what the oncologist should know
  Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo, Xiao Zhu
  Cancer Cell International.2020;[Epub]     CrossRef
• Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
  Chul Kyu Roh, Yoon Young Choi, Seohee Choi, Won Jun Seo, Minah Cho, Eunji Jang, Taeil Son, Hyoung-Il Kim, Hyeseon Kim, Woo Jin Hyung, Yong-Min Huh, Sung Hoon Noh, Jae-Ho Cheong
  Yonsei Medical Journal.2019; 60(2): 132.     CrossRef
• Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon
  Yoon Young Choi, Minah Cho, In Gyu Kwon, Taeil Son, Hyoung-Il Kim, Seung Ho Choi, Jae-Ho Cheong, Woo Jin Hyung
  Yonsei Medical Journal.2019; 60(3): 235.     CrossRef
• Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
  Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
  Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
• Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer
  Mengsha Tong, Chunyu Yu, Jinwen Shi, Wenwen Huang, Sai Ge, Mingwei Liu, Lei Song, Dongdong Zhan, Xia Xia, Wanlin Liu, Jinwen Feng, Wenhao Shi, Jiafu Ji, Jing Gao, Tieliu Shi, Weimin Zhu, Chen Ding, Yi Wang, Fuchu He, Lin Shen, Tingting Li, Jun Qin
  iScience.2019; 22: 44.     CrossRef
• Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
  Jiwon Koh, Soo Kyung Nam, Youn Woo Lee, Jin Won Kim, Keun-Wook Lee, Chan-Young Ock, Do-Youn Oh, Sang-Hoon Ahn, Hyung-Ho Kim, Keon-Wook Kang, Woo Ho Kim, Ho-Young Lee, Hye Seung Lee
  Biomolecules.2019; 9(12): 782.     CrossRef
• Targeted drug delivery of capecitabine to mice xenograft gastric cancer by PAMAM dendrimer nanocarrier
  Sharareh Jafari, Fatemeh Nabavizadeh, Jalal Vahedian, Mehdi Shafie Ardestani, Hedayat Samandari, Ali Zare Mehrjerdi
  african journal of gastroenterology and hepatology.2019; 2(1): 28.     CrossRef
• New therapeutic options opened by the molecular classification of gastric cancer
  Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu
  World Journal of Gastroenterology.2018; 24(18): 1942.     CrossRef
• Proposed Molecular and miRNA Classification of Gastric Cancer
  Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
  International Journal of Molecular Sciences.2018; 19(6): 1683.     CrossRef
• High serum MMP-14 predicts worse survival in gastric cancer
  Aaro Kasurinen, Taina Tervahartiala, Alli Laitinen, Arto Kokkola, Timo Sorsa, Camilla Böckelman, Caj Haglund, Dajun Deng
  PLOS ONE.2018; 13(12): e0208800.     CrossRef
• miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway
  Jianjun Wang, Yang Jiao, Lunmeng Cui, Lili Jiang
  Bioscience, Biotechnology, and Biochemistry.2017; 81(1): 119.     CrossRef
• Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients
  Jiwon Koh, Hee Eun Lee, Woo Ho Kim, Hye Seung Lee, Ju-Seog Lee
  PLOS ONE.2017; 12(3): e0174814.     CrossRef
• Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
  Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech
  Scandinavian Journal of Gastroenterology.2017; 52(6-7): 647.     CrossRef
• Molecular classifications of gastric cancers: Novel insights and possible future applications
  Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino, Mariella Giovannoni, Nicoletta Pella, Mario Scartozzi, Lorenzo Antonuzzo,
  World Journal of Gastrointestinal Oncology.2017; 9(5): 194.     CrossRef
• GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
  Puja Khanna, Pei Jou Chua, Belinda Shu Ee Wong, Changhong Yin, Aye Aye Thike, Wei Keat Wan, Puay Hoon Tan, Gyeong Hun Baeg
  Oncotarget.2017; 8(70): 115370.     CrossRef
• Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
  Jiwon Koh, Chan-Young Ock, Jin Won Kim, Soo Kyung Nam, Yoonjin Kwak, Sumi Yun, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
  Oncotarget.2017; 8(16): 26356.     CrossRef